Cargando…

High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma

BACKGROUND: S100A2, a member of the S100 protein family, is abnormally expressed and plays a vital role in multiple cancers. However, little is known about the clinical significance of S100A2 in endometrial carcinoma. METHODS: Clinicopathological data were obtained from The Cancer Genome Atlas (TCGA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Qinzhen, Xia, Tianxiang, Qi, Chenxiang, Du, Jun, Ye, Chunping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764844/ https://www.ncbi.nlm.nih.gov/pubmed/35042454 http://dx.doi.org/10.1186/s12885-022-09180-5

Ejemplares similares

High tyrosine threonine kinase expression predicts a poor prognosis: a potential therapeutic target for endometrial carcinoma
por: Cui, Chun-Hong, et al.
Publicado: (2022)

High expression of TARS is associated with poor prognosis of endometrial cancer
por: Si, Lihui, et al.
Publicado: (2023)

Low Expression of RILPL2 Predicts Poor Prognosis and Correlates With Immune Infiltration in Endometrial Carcinoma
por: Liu, Jinhui, et al.
Publicado: (2021)

High Nuclear Expression of HDGF Correlates with Disease Progression and Poor Prognosis in Human Endometrial Carcinoma
por: Wang, Lijing, et al.
Publicado: (2014)

Overexpression of MYBL2 predicts poor prognosis and promotes oncogenesis in endometrial carcinoma
por: Le, Lulu, et al.
Publicado: (2021)

High AKAP8L expression predicts poor prognosis in esophageal squamous cell carcinoma
por: Luo, Qiu-yun, et al.
Publicado: (2022)

High MICAL-L2 expression and its role in the prognosis of colon adenocarcinoma
por: Yang, Yixing, et al.
Publicado: (2022)

High expression of PARD3 predicts poor prognosis in hepatocellular carcinoma
por: Li, Songwei, et al.
Publicado: (2021)

High Expression of POGK Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma
por: Xu, Wenxiong, et al.
Publicado: (2022)

High expression of ENPP1 in high-grade serous ovarian carcinoma predicts poor prognosis and as a molecular therapy target
por: Wang, Hanzhi, et al.
Publicado: (2021)

High SIRPA Expression Predicts Poor Prognosis and Correlates with Immune Infiltrates in Patients with Esophageal Carcinoma
por: Tao, Ke, et al.
Publicado: (2022)

High expression of thymosin beta 10 predicts poor prognosis for hepatocellular carcinoma after hepatectomy
por: Wang, Haoyuan, et al.
Publicado: (2014)

Elevated Expression of Gamma-Glutamyl Hydrolase Is Associated With Poor Prognosis and Altered Immune Signature in Uterine Corpus Endometrial Carcinoma
por: Yu, Cong, et al.
Publicado: (2022)

High expression of PDGFA predicts poor prognosis of esophageal squamous cell carcinoma
por: Han, Na, et al.
Publicado: (2021)

Highly expressed FAM189B predicts poor prognosis in hepatocellular carcinoma
por: Ma, Wanshan, et al.
Publicado: (2022)

High S100A9(+) cell density predicts a poor prognosis in hepatocellular carcinoma patients after curative resection
por: Liao, Jing, et al.
Publicado: (2021)

High expression of HEF1 is associated with poor prognosis in urinary bladder carcinoma
por: Zhang, Qi, et al.
Publicado: (2014)

Pretreatment thrombocytosis predict poor prognosis in patients with endometrial carcinoma: a systematic review and meta-analysis
por: Nie, Dan, et al.
Publicado: (2019)

Decreased DC-SIGNR expression in hepatocellular carcinoma predicts poor patient prognosis
por: Xia, Hai-Bing, et al.
Publicado: (2020)

Expression of P-REX2a is associated with poor prognosis in endometrial malignancies
por: Takeshita, Sho, et al.
Publicado: (2018)

Expression of N-acetylglucosaminyltransferase V in endometrial cancer correlates with poor prognosis
por: Yamamoto, E, et al.
Publicado: (2007)

High TGF-β1 expression predicts poor disease prognosis in hepatocellular carcinoma patients
por: Peng, Li, et al.
Publicado: (2017)

High expression of CHML predicts poor prognosis of multiple myeloma
por: Zhang, Weilong, et al.
Publicado: (2019)

MICAL2 contributes to gastric cancer cell migration via Cdc42-dependent activation of E-cadherin/β-catenin signaling pathway
por: Wang, Qianwen, et al.
Publicado: (2022)

Decreased CRHBP expression is predictive of poor prognosis in patients with hepatocellular carcinoma
por: Xia, Hai-Bing, et al.
Publicado: (2018)

Upregulation of RECQL4 expression predicts poor prognosis in hepatocellular carcinoma
por: Li, Jun, et al.
Publicado: (2018)

High expression of FER tyrosine kinase predicts poor prognosis in clear cell renal cell carcinoma
por: WEI, CAN, et al.
Publicado: (2013)

High L1CAM expression predicts poor prognosis of patients with endometrial cancer: A systematic review and meta-analysis
por: Guo, Min, et al.
Publicado: (2021)

Elevated expression of LPCAT1 predicts a poor prognosis and is correlated with the tumour microenvironment in endometrial cancer
por: Zhao, Tianyi, et al.
Publicado: (2021)

High MICAL1 expression correlates with cancer progression and immune infiltration in renal clear cell carcinoma
por: Yang, Yixing, et al.
Publicado: (2022)

High expression of Linc00959 predicts poor prognosis in breast cancer
por: Chi, Weiru, et al.
Publicado: (2019)

High expression of GNA13 is associated with poor prognosis in hepatocellular carcinoma
por: Xu, Yi, et al.
Publicado: (2016)

High KIAA1522 expression predicts a poor prognosis in patients with hepatocellular carcinoma
por: Xu, Yongzheng, et al.
Publicado: (2020)

High expression of RPL27A predicts poor prognosis in patients with hepatocellular carcinoma
por: Xing, Huiwu, et al.
Publicado: (2023)

Stanniocalcin 2 expression predicts poor prognosis of hepatocellular carcinoma
por: ZHANG, ZHEN-HAI, et al.
Publicado: (2014)

High Spy1 expression predicts poor prognosis in colorectal cancer
por: Jin, Qin, et al.
Publicado: (2018)

High Expression of FCRLB Predicts Poor Prognosis in Patients With Colorectal Cancer
por: Wang, Xiaopeng, et al.
Publicado: (2022)

High expression of EMP1 predicts a poor prognosis and correlates with immune infiltrates in bladder urothelial carcinoma
por: Lin, Bo, et al.
Publicado: (2020)

High expression of p300 is linked to aggressive features and poor prognosis of Nasopharyngeal Carcinoma
por: Liao, Zhi-Wei, et al.
Publicado: (2012)

Critical weight loss predicts poor prognosis in nasopharyngeal carcinoma
por: Zeng, Qi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_pshke1pu7g7uplgaikmr0qileu